Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Axolabs, Mirrx, TriPhos, and More


Title: Alternative Export Pathways for Vector-expressed RNA Interference

Patent Number: 8,691,567

Filed: June 21, 2012

Lead Inventor: Scott Harper, University of Iowa

Title: Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds

Patent Number: 8,691,750

Filed: May 8, 2012

Lead Inventor: Rainer Constien, Axolabs

Title: Compositions for Treating Respiratory Viral Infections and Their Use

Patent Number: 8,691,781

Filed: June 1, 2007

Lead Inventor: Qingquan Tang, Sirnaomics

Title: Compositions and Methods for Non-parenteral Delivery of Oligonucleotides

Patent Number: 8,691,785

Filed: Jan. 7, 2013

Lead Inventor: Ching-Leou Teng, Isis Pharmaceuticals

Title: Methods and Compositions for the Specific Inhibition of Gene Expression by Double-stranded RNA

Patent Number: 8,691,786

Filed: Jan. 24, 2013

Lead Inventor: John Rossi, City of Hope

Title: Delivering Functional Nucleic Acids to Mammalian Cells via Bacterially Derived, Intact Minicells

Patent Number: 8,691,963

Filed: Aug. 25, 2005

Lead Inventor: Himanshu Brahmbhatt, Engeneic Molecular Delivery

Title: Oligonucleotides for Modulating Target RNA Activity

Patent Number: 8,691,965

Filed: June 13, 2008

Inventor: Thorleif Moller, Mirrx Therapeutics

Title: Multiple Promoter Expression Cassettes for Simultaneous Delivery of RNAi Agents

Patent Number: 8,691,967

Filed: Sept. 26, 2012

Lead Inventor: Petrus Roelvink, Benitec

Title: Self-delivering Bio-labile Phosphate Pro-oligos for Oligonucleotide-based Therapeutics and Mediating RNA Interference

Patent Number: 8,691,971

Filed: Sept. 23, 2009

Inventor: Scott Petersen, Traversa Therapeutics (TriPhos Therapeutics)